Zobrazeno 1 - 10
of 16
pro vyhledávání: '"HeeJin Cheon"'
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 919-923 (2022)
Abstract Large granular lymphocyte leukemia is a rare chronic lymphoproliferative disorder of cytotoxic cells. Other hematological malignancies such as CLL and multiple myeloma have been associated with poor vaccination response and markedly increase
Externí odkaz:
https://doaj.org/article/1ad749cb65a5430880773ac363014c38
Autor:
Gregorio Barilà, Angela Grassi, HeeJin Cheon, Antonella Teramo, Giulia Calabretto, Jasmanet Chahal, Cristina Vicenzetto, Julia Almeida, Bryna C. Shemo, Min Shi, Vanessa Rebecca Gasparini, Noemi Munoz-Garcia, Cédric Pastoret, Hideyuki Nakazawa, Kazuo Oshimi, Lubomir Sokol, Fumihiro Ishida, Thierry Lamy, Alberto Orfao, William G. Morice, Thomas P. Loughran, Gianpietro Semenzato, Renato Zambello
Publikováno v:
Blood
Blood, 2023, 141 (9), pp.1036-1046. ⟨10.1182/blood.2021013489⟩
Blood, 2023, 141 (9), pp.1036-1046. ⟨10.1182/blood.2021013489⟩
Tγδ large granular lymphocyte leukemia (LGLL) is a rare variant of T-cell LGLL (T-LGLL) that has been less investigated as compared with the more frequent Tαβ LGLL, particularly in terms of frequency of STAT3 and STAT5b mutations. In this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8337c12635d47995d56965c2da38d56d
https://hdl.handle.net/11577/3473451
https://hdl.handle.net/11577/3473451
Autor:
Carol Fries, Andrew G. Evans, HeeJin Cheon, David N. Korones, Thomas P. Loughran, Jeffrey R. Andolina
Publikováno v:
Journal of Pediatric Hematology/Oncology. 44:e960-e963
T-cell large granular lymphocytic (T-LGL) leukemia is a rare, typically indolent neoplasm with a median age of onset above 60 years. Pathogenesis involves clonal T-cell expansion, and nearly all reported pediatric cases have been associated with conc
Autor:
Thomas P. Loughran, Kristine C. Olson, Karolina H. Dziewulska, Katharine B. Moosic, HeeJin Cheon, David J. Feith
Publikováno v:
The Peripheral T‐Cell Lymphomas. :183-201
Autor:
Ulrich Siebenlist, Hongshan Wang, Sun Saret, Wanhu Tang, Estefania Claudio, HeeJin Cheon, Ruxiao Tian
Publikováno v:
European Journal of Immunology. 51:197-205
Bcl-3 is an atypical member of the IκB family that modulates NF-κB activity in nuclei. lpr mice carry the lpr mutation in Fas, resulting in functional loss of this death receptor; they serve as models for lupus erythematosus and autoimmune lymphopr
Autor:
Constance Baer, Shunsuke Kimura, Mitra S. Rana, Andrew B. Kleist, Tim Flerlage, David J. Feith, Peter Chockley, Wencke Walter, Manja Meggendorfer, Thomas L. Olson, HeeJin Cheon, Kristine C. Olson, Aakrosh Ratan, Martha-Lena Mueller, James M. Foran, Laura J. Janke, Chunxu Qu, Shaina N. Porter, Shondra M. Pruett-Miller, Ravi C. Kalathur, Claudia Haferlach, Wolfgang Kern, Elisabeth Paietta, Paul G. Thomas, M. Madan Babu, Thomas P. Loughran, Ilaria Iacobucci, Torsten Haferlach, Charles G. Mullighan
Publikováno v:
Nature genetics. 54(5)
Chronic lymphoproliferative disorder of natural killer cells (CLPD-NK) is characterized by clonal expansion of natural killer (NK) cells where the underlying genetic mechanisms are incompletely understood. In the present study, we report somatic muta
Autor:
James M. Foran, Mitra S Rana, Andrew B. Kleist, Martha-Lena Mueller, Claudia Haferlach, David J. Feith, Ravi C. Kalathur, Thomas P. Loughran, Manja Meggendorfer, Aakrosh Ratan, Ilaria Iacobucci, Thomas L. Olson, HeeJin Cheon, Laura J. Janke, Kristine C. Olson, Wencke Walter, Constance Baer, Torsten Haferlach, Elisabeth Paietta, Charles G. Mullighan, M. Madan Babu, Shunsuke Kimura, Wolfgang Kern, Chunxu Qu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S320-S321
Context: Chronic lymphoproliferative disorder of natural killer cells (CLPD-NK) is a subset of large granular lymphocyte (LGL) leukemia included as a provisional entity in the 2016 WHO classification of lymphoid neoplasms, which is characterized by c
Autor:
Kristine C. Olson, HeeJin Cheon, Katharine B. Moosic, David J. Feith, Karolina H. Dziewulska, Alejandro A. Gru, Thomas P. Loughran
Publikováno v:
Curr Hematol Malig Rep
PURPOSE OF REVIEW: The past decade in LGL leukemia research has seen increased pairing of clinical data with molecular markers, shedding new insights on LGL leukemia pathogenesis and heterogeneity. This review summarizes the current standard of care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ebcdfe24459b8092b74663f47769be
https://europepmc.org/articles/PMC7234906/
https://europepmc.org/articles/PMC7234906/
Autor:
John S. Wang, Thomas P. Loughran, Aakrosh Ratan, Farid Ghamsari, David J. Feith, Vivian Chan, HeeJin Cheon, Omar Elghawy
Publikováno v:
Blood. 138:2464-2464
Introduction: Large Granular Lymphocyte (LGL) leukemia is a rare lymphoproliferative disorder usually manifested in elderly individuals, with mean age of onset at 65. However, LGL leukemia cases in pediatric and young adult (age 50) cohort. Methods: